These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29589375)

  • 21. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator.
    Mohsen A; Jimenez A; Hood RE; Dickfeld T; Saliaris A; Shorofsky S; Saba MM
    J Cardiovasc Electrophysiol; 2014 Feb; 25(2):171-6. PubMed ID: 24433308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
    Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators.
    Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Kambouraki DC; Arfanakis DA; Vardas PE
    Chest; 2005 Oct; 128(4):2604-10. PubMed ID: 16236931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A modified subcutaneous implantable cardioverter-defibrillator implant in a patient with a previous left ventricular epicardial defibrillation patch.
    Mehta PA; Bostock J; Rinaldi CA
    Europace; 2012 Jan; 14(1):149-50. PubMed ID: 21873629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible ventricular tachycardia due to dermatomyositis-related cardiomyopathy in the era of implantable cardioverter-defibrillator therapy.
    Dilaveris P; Pietri P; Tsiachris D; Gatzoulis K; Stefanadis C
    Circulation; 2012 Feb; 125(7):967-9. PubMed ID: 22354978
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiomyoplasty combined with implantation of a cardioverter defibrillator.
    Chekanov VS; Deshpande S; Schmidt DH
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):489-91. PubMed ID: 9305204
    [No Abstract]   [Full Text] [Related]  

  • 30. Irregular Tachycardia in a Patient With Cardiomyopathy: It Takes Two to Tango.
    Nabavizadeh P; Rajsheker S; Attari M
    Circulation; 2020 Mar; 141(9):775-780. PubMed ID: 32119584
    [No Abstract]   [Full Text] [Related]  

  • 31. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two adults requiring implantable defibrillators because of ventricular tachycardia and left ventricular dysfunction caused by presumed Kawasaki disease.
    Yagi S; Tsuda E; Shimizu W; Kurita T; Seguchi O; Nonogi H; Kamakura S
    Circ J; 2005 Jul; 69(7):870-4. PubMed ID: 15988116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated noncompaction of the ventricular myocardium: contemporary diagnosis and management.
    Chrissoheris MP; Ali R; Vivas Y; Marieb M; Protopapas Z
    Clin Cardiol; 2007 Apr; 30(4):156-60. PubMed ID: 17443648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ventricular tachycardia revealed by a left ventricular non-compaction].
    Szymanski C; Otmani A; Leborgne L; Quenum S; Bakkour H; Bertrand C; Rey JL
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):319-23. PubMed ID: 17977507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator.
    Casset-Senon D; Philippe L; Renard JP; Cosnay P
    J Nucl Cardiol; 2008; 15(2):282-5. PubMed ID: 18371601
    [No Abstract]   [Full Text] [Related]  

  • 36. An appropriate implantable cardioverter-defibrillator shock triggering unusual phenomenons.
    Arias MA; Puchol A; Colchero T; Pachón M; Castellanos E; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1157-60. PubMed ID: 20487346
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study.
    Jiménez-Candil J; Anguera I; Durán O; Hernández J; Fernández-Portales J; Moríñigo JL; Martín A; Dallaglio P; Bravo L; di Marco A; Sánchez PL
    J Interv Card Electrophysiol; 2018 Jun; 52(1):69-76. PubMed ID: 29557531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification for ventricular arrhythmias in ischaemic cardiomyopathy: the value of non-invasive imaging.
    de Haan S; Knaapen P; Beek AM; de Cock CC; Lammertsma AA; van Rossum AC; Allaart CP
    Europace; 2010 Apr; 12(4):468-74. PubMed ID: 20338987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitachycardia pacing: A worthy cause?
    Ho G; Birgersdotter-Green U
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2727-2729. PubMed ID: 32700345
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.